Focal Therapy Use Remains Uncommon in Nonmetastatic Prostate Cancer

THURSDAY, Sept. 3, 2026-- For patients with nonmetastatic prostate cancer, focal therapy use has remained uncommon across risk groups, and its use is defined as inappropriate in about half of recipients, according to a research letter published...